1. Mangum, Kevin D, Freeman, Emily J, Magin, Justin C, Taylor, Joan M, Mack, Christopher P. 2019. Transcriptional and posttranscriptional regulation of the SMC-selective blood pressure-associated gene, ARHGAP42. In American journal of physiology. Heart and circulatory physiology, 318, H413-H424. doi:10.1152/ajpheart.00143.2019. https://pubmed.ncbi.nlm.nih.gov/31886719/
2. Fjorder, Amanda S, Rasmussen, Malene B, Mehrjouy, Mana M, Tommerup, Niels, Bache, Iben. 2019. Haploinsufficiency of ARHGAP42 is associated with hypertension. In European journal of human genetics : EJHG, 27, 1296-1303. doi:10.1038/s41431-019-0382-9. https://pubmed.ncbi.nlm.nih.gov/30903111/
3. Bai, Xue, Mangum, Kevin D, Dee, Rachel A, Taylor, Joan M, Mack, Christopher P. 2017. Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. In The Journal of clinical investigation, 127, 670-680. doi:10.1172/JCI88899. https://pubmed.ncbi.nlm.nih.gov/28112683/
4. Hu, Qian, Lin, Xiao, Ding, Linxiaoxiao, Xiang, Yanqun, Yao, Herui. 2018. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma. In Cancer medicine, 7, 3862-3874. doi:10.1002/cam4.1552. https://pubmed.ncbi.nlm.nih.gov/29936709/
5. Li, Qifei, Dibus, Michal, Casey, Alicia, Rosel, Daniel, Agrawal, Pankaj B. 2021. A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. In PLoS genetics, 17, e1009639. doi:10.1371/journal.pgen.1009639. https://pubmed.ncbi.nlm.nih.gov/34232960/
6. Wang, Miaomiao, Zhou, Zhike, Wang, Yingying, Wang, Lixin. 2025. The gene-panel obtained by anti-PD-1 monotherapy for melanoma reveals prognostic markers and therapeutic targets. In Journal of chemotherapy (Florence, Italy), , 1-14. doi:10.1080/1120009X.2025.2465013. https://pubmed.ncbi.nlm.nih.gov/39948732/
7. Betancor, Yoel Z, Ferreiro-Pantín, Miriam, Anido-Herranz, Urbano, López-López, Rafael, Ruiz-Bañobre, Juan. 2024. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma. In Frontiers in immunology, 15, 1374728. doi:10.3389/fimmu.2024.1374728. https://pubmed.ncbi.nlm.nih.gov/38660294/
智鼠故事 
